Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this study is to assess time to discontinuation due to lack of tolerability among patients with schizophrenia receiving up to 52 weeks of LY2140023, given orally twice daily, compared with those on atypical antipsychotic standard-of-care treatment. Lack of tolerability is defined as discontinuation due to adverse events (AEs).
Inclusion criteria
- Schizophrenia